Drug Utilization Review Board

DUR Board Overview

The Mississippi Division of Medicaid’s Drug Utilization Review (DUR) Board is a quality assurance body which seeks to assure appropriate drug therapy to include optimal beneficiary outcomes and appropriate education for providers and beneficiaries. The Board reviews utilization of drug therapy and evaluates the long-term success of the treatments.

Mississippi Evidence-Based DUR Initiative

Working closely with Mississippi Medicaid staff, the Mississippi Evidence-Based DUR Initiative (MS-DUR) performs retrospective drug utilization review (DUR) functions through claims review and analysis. This important work is vital to the activities of the DUR Board.

In addition to supporting Mississippi Medicaid and the DUR Board, MS-DUR’s work also results in the production of many research reports, clinical presentations, and publications. Please visit the  MS-DUR website for access to this important information, as well as helpful resources for Medicaid providers.

Recent articles/submissions:

Factors influencing Human papillomavirus (HPV) vaccination series completion in Mississippi Medicaid. 

Inguva S, Barnard M, Ward LM, Yang Y, Pittman E, Banahan BF 3rd, Kirby TR, Noble SL.  Vaccine. 2020 Feb 18;38(8):2051-2057. doi: 10.1016/j.vaccine.2019.12.030. Epub 2020 Jan 21. PMID: 31980196.

DUR Board Meeting Resources

Members

The DUR Board is composed of twelve participating Medicaid providers who are in good standing with their representative organizations.

• DUR Board Member List

Meetings

2021 dates: March 4, 2021; June 10, 2021; September 16, 2021; and December 9, 2021.

Important Update: beginning July 1, 2021, pharmaceutical and industry members, vendors, and general public must register to attend. Registration will open thirty (30) days prior to the meeting date. Registrants will be emailed attendance link information the day before the meeting.

DUR Board Information | DUR Board Packets & Meeting Minutes Archive